DM
ITCI

Deerfield Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Deerfield Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,910
Closed -$208K – 437
2023
Q4 		$208K Buy
+2,910
New +$167K ﹤0.01% 170
2023
Q2 		– Sell
-734,000
Closed -$39.7M – 112
2023
Q1 		$39.7M Buy
+734,000
New +$35.5M 0.89% 35
2017
Q4 		– Sell
-118,116
Closed -$1.86M – 105
2017
Q3 		$1.86M Buy
+118,116
New +$1.73M 0.08% 89
2014
Q2 		– Sell
-171,437
Closed -$3.12M – 152
2014
Q1 		$3.12M Buy
+171,437
New +$3.09M 0.14% 102

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return